229 related articles for article (PubMed ID: 30638294)
21. Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Gupta AK; Paquet M
Br J Dermatol; 2013 Aug; 169(2):250-9. PubMed ID: 23550994
[TBL] [Abstract][Full Text] [Related]
22. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
Jorizzo J; Weiss J; Vamvakias G
J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
[TBL] [Abstract][Full Text] [Related]
23. Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil.
Segatto MM; Dornelles SI; Silveira VB; Frantz Gde O
An Bras Dermatol; 2013; 88(5):732-8. PubMed ID: 24173178
[TBL] [Abstract][Full Text] [Related]
24. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
25. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Nguyen HP; Rivers JK
Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
[TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.
Steeb T; Heppt MV; Becker L; Kohl C; French LE; Berking C
Syst Rev; 2019 Oct; 8(1):237. PubMed ID: 31604446
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of low-dose 5-fluorouracil/salicylic acid in actinic keratoses in relation to treatment duration.
Szeimies RM; Dirschka T; Prechtl A; Melzer A
J Dtsch Dermatol Ges; 2015 May; 13(5):430-8. PubMed ID: 25918087
[TBL] [Abstract][Full Text] [Related]
28. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
29. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses.
Yentzer B; Hick J; Williams L; Inabinet R; Wilson R; Camacho FT; Russell GB; Feldman SR
Arch Dermatol; 2009 Feb; 145(2):203-5. PubMed ID: 19221274
[No Abstract] [Full Text] [Related]
30. Short incubation PDT versus 5-FU in treating actinic keratoses.
Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
[TBL] [Abstract][Full Text] [Related]
31. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
32. In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5-fluorouracil.
Ishioka P; Maia M; Rodrigues SB; Lellis RF; Hirata SH
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1155-1163. PubMed ID: 29178474
[TBL] [Abstract][Full Text] [Related]
33. Cryosurgery combined with topical interventions for actinic keratosis: a systematic review and meta-analysis.
Heppt MV; Steeb T; Ruzicka T; Berking C
Br J Dermatol; 2019 Apr; 180(4):740-748. PubMed ID: 30447074
[TBL] [Abstract][Full Text] [Related]
34. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
Pei S; Kaminska ECN; Tsoukas MM
Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
[TBL] [Abstract][Full Text] [Related]
35. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
[TBL] [Abstract][Full Text] [Related]
36. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.
Couch SM; Custer PL
Ophthalmic Plast Reconstr Surg; 2012; 28(3):181-3. PubMed ID: 22460673
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results.
Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Goncalves J; Larsson T; Skov T; Swanson N
J Drugs Dermatol; 2014 Feb; 13(2):154-60. PubMed ID: 24509965
[TBL] [Abstract][Full Text] [Related]
38. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
Kaur RR; Alikhan A; Maibach HI
J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the tolerability and safety of a 0.015% ingenol mebutate gel compared to 5% 5-fluorouracil cream for the treatment of facial actinic keratosis: a prospective randomized trial.
Samorano LP; Torezan LA; Sanches JA
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1822-7. PubMed ID: 25727104
[TBL] [Abstract][Full Text] [Related]
40. Five percent 5-fluorouracil in a cream or for superficial peels in the treatment of advanced photoaging of the forearms: a randomized comparative study.
Guimarães CO; Miot HA; Bagatin E
Dermatol Surg; 2014 Jun; 40(6):610-7. PubMed ID: 24852464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
